ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ranitidine (Zantac) Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-0Q9426
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Ranitidine Zantac Market Outlook 2022
BUY CHAPTERS

Global Ranitidine (Zantac) Market Research Report 2025

Code: QYRE-Auto-0Q9426
Report
April 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi Aventis
GlaxoSmithKline PLC
Hi-Tech Pharmacal Co.
Sun Pharma
Mylan Pharmaceuticals Inc. (and Mylan Laboratories)
Dr. Reddy’s Laboratories, Inc.
Sandoz Inc. (part of Novartis AG)
Strides (and Strides Arcolab international)
Geri-Care Pharmaceuticals
PAI Holdings, LLC
Teva Pharmaceuticals
Granules Pharmaceuticals Inc.
Glenmark Pharmaceuticals (and Glenmark Generics)
Apotex Inc. (and Apotex Corporation)
Hikma Pharmaceuticals (West-ward Pharmaceuticals)

Ranitidine (Zantac) Market

The global market for Ranitidine (Zantac) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Ranitidine (Zantac) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Ranitidine (Zantac) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Ranitidine (Zantac) include Sanofi-Aventis, GlaxoSmithKline, Hi-Tech Pharmacal Co., Sun Pharma, Mylan Pharmaceuticals Inc. (and Mylan Laboratories), Dr. Reddy’s Laboratories Inc., Sandoz Inc. (part of Novartis AG), Strides (and Strides Arcolab international), Geri-Care Pharmaceuticals, PAI Holdings, LLC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ranitidine (Zantac), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ranitidine (Zantac).
The Ranitidine (Zantac) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ranitidine (Zantac) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ranitidine (Zantac) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Ranitidine (Zantac) Market Report

Report Metric Details
Report Name Ranitidine (Zantac) Market
Segment by Type
  • Ranitidine Capsule
  • Ranitidine Oral Tablet
  • Ranitidine Injectable Solution
  • Ranitidine Oral Syrup
Segment by Application
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi-Aventis, GlaxoSmithKline, Hi-Tech Pharmacal Co., Sun Pharma, Mylan Pharmaceuticals Inc. (and Mylan Laboratories), Dr. Reddy’s Laboratories Inc., Sandoz Inc. (part of Novartis AG), Strides (and Strides Arcolab international), Geri-Care Pharmaceuticals, PAI Holdings, LLC, Teva Pharmaceuticals, Granules Pharmaceuticals Inc., Glenmark Pharmaceuticals (and Glenmark Generics), Apotex Inc. (and Apotex Corporation), Hikma Pharmaceuticals (West-ward Pharmaceuticals)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Ranitidine (Zantac) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Ranitidine (Zantac) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Ranitidine (Zantac) Market report?

Ans: The main players in the Ranitidine (Zantac) Market are Sanofi-Aventis, GlaxoSmithKline, Hi-Tech Pharmacal Co., Sun Pharma, Mylan Pharmaceuticals Inc. (and Mylan Laboratories), Dr. Reddy’s Laboratories Inc., Sandoz Inc. (part of Novartis AG), Strides (and Strides Arcolab international), Geri-Care Pharmaceuticals, PAI Holdings, LLC, Teva Pharmaceuticals, Granules Pharmaceuticals Inc., Glenmark Pharmaceuticals (and Glenmark Generics), Apotex Inc. (and Apotex Corporation), Hikma Pharmaceuticals (West-ward Pharmaceuticals)

What are the Application segmentation covered in the Ranitidine (Zantac) Market report?

Ans: The Applications covered in the Ranitidine (Zantac) Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Ranitidine (Zantac) Market report?

Ans: The Types covered in the Ranitidine (Zantac) Market report are Ranitidine Capsule, Ranitidine Oral Tablet, Ranitidine Injectable Solution, Ranitidine Oral Syrup

1 Ranitidine (Zantac) Market Overview
1.1 Product Definition
1.2 Ranitidine (Zantac) by Type
1.2.1 Global Ranitidine (Zantac) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Ranitidine Capsule
1.2.3 Ranitidine Oral Tablet
1.2.4 Ranitidine Injectable Solution
1.2.5 Ranitidine Oral Syrup
1.3 Ranitidine (Zantac) by Application
1.3.1 Global Ranitidine (Zantac) Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Ranitidine (Zantac) Market Size Estimates and Forecasts
1.4.1 Global Ranitidine (Zantac) Revenue 2020-2031
1.4.2 Global Ranitidine (Zantac) Sales 2020-2031
1.4.3 Global Ranitidine (Zantac) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Ranitidine (Zantac) Market Competition by Manufacturers
2.1 Global Ranitidine (Zantac) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Ranitidine (Zantac) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Ranitidine (Zantac) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Ranitidine (Zantac), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ranitidine (Zantac), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ranitidine (Zantac), Product Type & Application
2.7 Global Key Manufacturers of Ranitidine (Zantac), Date of Enter into This Industry
2.8 Global Ranitidine (Zantac) Market Competitive Situation and Trends
2.8.1 Global Ranitidine (Zantac) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Ranitidine (Zantac) Players Market Share by Revenue
2.8.3 Global Ranitidine (Zantac) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ranitidine (Zantac) Market Scenario by Region
3.1 Global Ranitidine (Zantac) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Ranitidine (Zantac) Sales by Region: 2020-2031
3.2.1 Global Ranitidine (Zantac) Sales by Region: 2020-2025
3.2.2 Global Ranitidine (Zantac) Sales by Region: 2026-2031
3.3 Global Ranitidine (Zantac) Revenue by Region: 2020-2031
3.3.1 Global Ranitidine (Zantac) Revenue by Region: 2020-2025
3.3.2 Global Ranitidine (Zantac) Revenue by Region: 2026-2031
3.4 North America Ranitidine (Zantac) Market Facts & Figures by Country
3.4.1 North America Ranitidine (Zantac) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Ranitidine (Zantac) Sales by Country (2020-2031)
3.4.3 North America Ranitidine (Zantac) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ranitidine (Zantac) Market Facts & Figures by Country
3.5.1 Europe Ranitidine (Zantac) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Ranitidine (Zantac) Sales by Country (2020-2031)
3.5.3 Europe Ranitidine (Zantac) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ranitidine (Zantac) Market Facts & Figures by Region
3.6.1 Asia Pacific Ranitidine (Zantac) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Ranitidine (Zantac) Sales by Region (2020-2031)
3.6.3 Asia Pacific Ranitidine (Zantac) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Ranitidine (Zantac) Market Facts & Figures by Country
3.7.1 Latin America Ranitidine (Zantac) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Ranitidine (Zantac) Sales by Country (2020-2031)
3.7.3 Latin America Ranitidine (Zantac) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ranitidine (Zantac) Market Facts & Figures by Country
3.8.1 Middle East and Africa Ranitidine (Zantac) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Ranitidine (Zantac) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Ranitidine (Zantac) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ranitidine (Zantac) Sales by Type (2020-2031)
4.1.1 Global Ranitidine (Zantac) Sales by Type (2020-2025)
4.1.2 Global Ranitidine (Zantac) Sales by Type (2026-2031)
4.1.3 Global Ranitidine (Zantac) Sales Market Share by Type (2020-2031)
4.2 Global Ranitidine (Zantac) Revenue by Type (2020-2031)
4.2.1 Global Ranitidine (Zantac) Revenue by Type (2020-2025)
4.2.2 Global Ranitidine (Zantac) Revenue by Type (2026-2031)
4.2.3 Global Ranitidine (Zantac) Revenue Market Share by Type (2020-2031)
4.3 Global Ranitidine (Zantac) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Ranitidine (Zantac) Sales by Application (2020-2031)
5.1.1 Global Ranitidine (Zantac) Sales by Application (2020-2025)
5.1.2 Global Ranitidine (Zantac) Sales by Application (2026-2031)
5.1.3 Global Ranitidine (Zantac) Sales Market Share by Application (2020-2031)
5.2 Global Ranitidine (Zantac) Revenue by Application (2020-2031)
5.2.1 Global Ranitidine (Zantac) Revenue by Application (2020-2025)
5.2.2 Global Ranitidine (Zantac) Revenue by Application (2026-2031)
5.2.3 Global Ranitidine (Zantac) Revenue Market Share by Application (2020-2031)
5.3 Global Ranitidine (Zantac) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi-Aventis
6.1.1 Sanofi-Aventis Company Information
6.1.2 Sanofi-Aventis Description and Business Overview
6.1.3 Sanofi-Aventis Ranitidine (Zantac) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi-Aventis Ranitidine (Zantac) Product Portfolio
6.1.5 Sanofi-Aventis Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Company Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Ranitidine (Zantac) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GlaxoSmithKline Ranitidine (Zantac) Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Hi-Tech Pharmacal Co.
6.3.1 Hi-Tech Pharmacal Co. Company Information
6.3.2 Hi-Tech Pharmacal Co. Description and Business Overview
6.3.3 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Product Portfolio
6.3.5 Hi-Tech Pharmacal Co. Recent Developments/Updates
6.4 Sun Pharma
6.4.1 Sun Pharma Company Information
6.4.2 Sun Pharma Description and Business Overview
6.4.3 Sun Pharma Ranitidine (Zantac) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sun Pharma Ranitidine (Zantac) Product Portfolio
6.4.5 Sun Pharma Recent Developments/Updates
6.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories)
6.5.1 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Company Information
6.5.2 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Description and Business Overview
6.5.3 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Product Portfolio
6.5.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Recent Developments/Updates
6.6 Dr. Reddy’s Laboratories Inc.
6.6.1 Dr. Reddy’s Laboratories Inc. Company Information
6.6.2 Dr. Reddy’s Laboratories Inc. Description and Business Overview
6.6.3 Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Product Portfolio
6.6.5 Dr. Reddy’s Laboratories Inc. Recent Developments/Updates
6.7 Sandoz Inc. (part of Novartis AG)
6.7.1 Sandoz Inc. (part of Novartis AG) Company Information
6.7.2 Sandoz Inc. (part of Novartis AG) Description and Business Overview
6.7.3 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Product Portfolio
6.7.5 Sandoz Inc. (part of Novartis AG) Recent Developments/Updates
6.8 Strides (and Strides Arcolab international)
6.8.1 Strides (and Strides Arcolab international) Company Information
6.8.2 Strides (and Strides Arcolab international) Description and Business Overview
6.8.3 Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Strides (and Strides Arcolab international) Ranitidine (Zantac) Product Portfolio
6.8.5 Strides (and Strides Arcolab international) Recent Developments/Updates
6.9 Geri-Care Pharmaceuticals
6.9.1 Geri-Care Pharmaceuticals Company Information
6.9.2 Geri-Care Pharmaceuticals Description and Business Overview
6.9.3 Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Geri-Care Pharmaceuticals Ranitidine (Zantac) Product Portfolio
6.9.5 Geri-Care Pharmaceuticals Recent Developments/Updates
6.10 PAI Holdings, LLC
6.10.1 PAI Holdings, LLC Company Information
6.10.2 PAI Holdings, LLC Description and Business Overview
6.10.3 PAI Holdings, LLC Ranitidine (Zantac) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 PAI Holdings, LLC Ranitidine (Zantac) Product Portfolio
6.10.5 PAI Holdings, LLC Recent Developments/Updates
6.11 Teva Pharmaceuticals
6.11.1 Teva Pharmaceuticals Company Information
6.11.2 Teva Pharmaceuticals Description and Business Overview
6.11.3 Teva Pharmaceuticals Ranitidine (Zantac) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Teva Pharmaceuticals Ranitidine (Zantac) Product Portfolio
6.11.5 Teva Pharmaceuticals Recent Developments/Updates
6.12 Granules Pharmaceuticals Inc.
6.12.1 Granules Pharmaceuticals Inc. Company Information
6.12.2 Granules Pharmaceuticals Inc. Description and Business Overview
6.12.3 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Product Portfolio
6.12.5 Granules Pharmaceuticals Inc. Recent Developments/Updates
6.13 Glenmark Pharmaceuticals (and Glenmark Generics)
6.13.1 Glenmark Pharmaceuticals (and Glenmark Generics) Company Information
6.13.2 Glenmark Pharmaceuticals (and Glenmark Generics) Description and Business Overview
6.13.3 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Product Portfolio
6.13.5 Glenmark Pharmaceuticals (and Glenmark Generics) Recent Developments/Updates
6.14 Apotex Inc. (and Apotex Corporation)
6.14.1 Apotex Inc. (and Apotex Corporation) Company Information
6.14.2 Apotex Inc. (and Apotex Corporation) Description and Business Overview
6.14.3 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Product Portfolio
6.14.5 Apotex Inc. (and Apotex Corporation) Recent Developments/Updates
6.15 Hikma Pharmaceuticals (West-ward Pharmaceuticals)
6.15.1 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Company Information
6.15.2 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Description and Business Overview
6.15.3 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Product Portfolio
6.15.5 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ranitidine (Zantac) Industry Chain Analysis
7.2 Ranitidine (Zantac) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ranitidine (Zantac) Production Mode & Process Analysis
7.4 Ranitidine (Zantac) Sales and Marketing
7.4.1 Ranitidine (Zantac) Sales Channels
7.4.2 Ranitidine (Zantac) Distributors
7.5 Ranitidine (Zantac) Customer Analysis
8 Ranitidine (Zantac) Market Dynamics
8.1 Ranitidine (Zantac) Industry Trends
8.2 Ranitidine (Zantac) Market Drivers
8.3 Ranitidine (Zantac) Market Challenges
8.4 Ranitidine (Zantac) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi Aventis
GlaxoSmithKline PLC
Hi-Tech Pharmacal Co.
Sun Pharma
Mylan Pharmaceuticals Inc. (and Mylan Laboratories)
Dr. Reddy’s Laboratories, Inc.
Sandoz Inc. (part of Novartis AG)
Strides (and Strides Arcolab international)
Geri-Care Pharmaceuticals
PAI Holdings, LLC
Teva Pharmaceuticals
Granules Pharmaceuticals Inc.
Glenmark Pharmaceuticals (and Glenmark Generics)
Apotex Inc. (and Apotex Corporation)
Hikma Pharmaceuticals (West-ward Pharmaceuticals)
List of Tables
 Table 1. Global Ranitidine (Zantac) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Ranitidine (Zantac) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Ranitidine (Zantac) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Ranitidine (Zantac) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Ranitidine (Zantac) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Ranitidine (Zantac) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Ranitidine (Zantac) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Ranitidine (Zantac) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Ranitidine (Zantac), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Ranitidine (Zantac), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Ranitidine (Zantac), Product Type & Application
 Table 12. Global Key Manufacturers of Ranitidine (Zantac), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Ranitidine (Zantac) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ranitidine (Zantac) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Ranitidine (Zantac) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Ranitidine (Zantac) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Ranitidine (Zantac) Sales Market Share by Region (2020-2025)
 Table 19. Global Ranitidine (Zantac) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Ranitidine (Zantac) Sales Market Share by Region (2026-2031)
 Table 21. Global Ranitidine (Zantac) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Ranitidine (Zantac) Revenue Market Share by Region (2020-2025)
 Table 23. Global Ranitidine (Zantac) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Ranitidine (Zantac) Revenue Market Share by Region (2026-2031)
 Table 25. North America Ranitidine (Zantac) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Ranitidine (Zantac) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Ranitidine (Zantac) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Ranitidine (Zantac) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Ranitidine (Zantac) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Ranitidine (Zantac) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Ranitidine (Zantac) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Ranitidine (Zantac) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Ranitidine (Zantac) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Ranitidine (Zantac) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Ranitidine (Zantac) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Ranitidine (Zantac) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Ranitidine (Zantac) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Ranitidine (Zantac) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Ranitidine (Zantac) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Ranitidine (Zantac) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Ranitidine (Zantac) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Ranitidine (Zantac) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Ranitidine (Zantac) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Ranitidine (Zantac) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Ranitidine (Zantac) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Ranitidine (Zantac) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Ranitidine (Zantac) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Ranitidine (Zantac) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Ranitidine (Zantac) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Ranitidine (Zantac) Sales (K Units) by Type (2020-2025)
 Table 51. Global Ranitidine (Zantac) Sales (K Units) by Type (2026-2031)
 Table 52. Global Ranitidine (Zantac) Sales Market Share by Type (2020-2025)
 Table 53. Global Ranitidine (Zantac) Sales Market Share by Type (2026-2031)
 Table 54. Global Ranitidine (Zantac) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Ranitidine (Zantac) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Ranitidine (Zantac) Revenue Market Share by Type (2020-2025)
 Table 57. Global Ranitidine (Zantac) Revenue Market Share by Type (2026-2031)
 Table 58. Global Ranitidine (Zantac) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Ranitidine (Zantac) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Ranitidine (Zantac) Sales (K Units) by Application (2020-2025)
 Table 61. Global Ranitidine (Zantac) Sales (K Units) by Application (2026-2031)
 Table 62. Global Ranitidine (Zantac) Sales Market Share by Application (2020-2025)
 Table 63. Global Ranitidine (Zantac) Sales Market Share by Application (2026-2031)
 Table 64. Global Ranitidine (Zantac) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Ranitidine (Zantac) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Ranitidine (Zantac) Revenue Market Share by Application (2020-2025)
 Table 67. Global Ranitidine (Zantac) Revenue Market Share by Application (2026-2031)
 Table 68. Global Ranitidine (Zantac) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Ranitidine (Zantac) Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi-Aventis Company Information
 Table 71. Sanofi-Aventis Description and Business Overview
 Table 72. Sanofi-Aventis Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi-Aventis Ranitidine (Zantac) Product
 Table 74. Sanofi-Aventis Recent Developments/Updates
 Table 75. GlaxoSmithKline Company Information
 Table 76. GlaxoSmithKline Description and Business Overview
 Table 77. GlaxoSmithKline Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GlaxoSmithKline Ranitidine (Zantac) Product
 Table 79. GlaxoSmithKline Recent Developments/Updates
 Table 80. Hi-Tech Pharmacal Co. Company Information
 Table 81. Hi-Tech Pharmacal Co. Description and Business Overview
 Table 82. Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Hi-Tech Pharmacal Co. Ranitidine (Zantac) Product
 Table 84. Hi-Tech Pharmacal Co. Recent Developments/Updates
 Table 85. Sun Pharma Company Information
 Table 86. Sun Pharma Description and Business Overview
 Table 87. Sun Pharma Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Sun Pharma Ranitidine (Zantac) Product
 Table 89. Sun Pharma Recent Developments/Updates
 Table 90. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Company Information
 Table 91. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Description and Business Overview
 Table 92. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Product
 Table 94. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Recent Developments/Updates
 Table 95. Dr. Reddy’s Laboratories Inc. Company Information
 Table 96. Dr. Reddy’s Laboratories Inc. Description and Business Overview
 Table 97. Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Product
 Table 99. Dr. Reddy’s Laboratories Inc. Recent Developments/Updates
 Table 100. Sandoz Inc. (part of Novartis AG) Company Information
 Table 101. Sandoz Inc. (part of Novartis AG) Description and Business Overview
 Table 102. Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Product
 Table 104. Sandoz Inc. (part of Novartis AG) Recent Developments/Updates
 Table 105. Strides (and Strides Arcolab international) Company Information
 Table 106. Strides (and Strides Arcolab international) Description and Business Overview
 Table 107. Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Strides (and Strides Arcolab international) Ranitidine (Zantac) Product
 Table 109. Strides (and Strides Arcolab international) Recent Developments/Updates
 Table 110. Geri-Care Pharmaceuticals Company Information
 Table 111. Geri-Care Pharmaceuticals Description and Business Overview
 Table 112. Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Geri-Care Pharmaceuticals Ranitidine (Zantac) Product
 Table 114. Geri-Care Pharmaceuticals Recent Developments/Updates
 Table 115. PAI Holdings, LLC Company Information
 Table 116. PAI Holdings, LLC Description and Business Overview
 Table 117. PAI Holdings, LLC Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. PAI Holdings, LLC Ranitidine (Zantac) Product
 Table 119. PAI Holdings, LLC Recent Developments/Updates
 Table 120. Teva Pharmaceuticals Company Information
 Table 121. Teva Pharmaceuticals Description and Business Overview
 Table 122. Teva Pharmaceuticals Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Teva Pharmaceuticals Ranitidine (Zantac) Product
 Table 124. Teva Pharmaceuticals Recent Developments/Updates
 Table 125. Granules Pharmaceuticals Inc. Company Information
 Table 126. Granules Pharmaceuticals Inc. Description and Business Overview
 Table 127. Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Granules Pharmaceuticals Inc. Ranitidine (Zantac) Product
 Table 129. Granules Pharmaceuticals Inc. Recent Developments/Updates
 Table 130. Glenmark Pharmaceuticals (and Glenmark Generics) Company Information
 Table 131. Glenmark Pharmaceuticals (and Glenmark Generics) Description and Business Overview
 Table 132. Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Product
 Table 134. Glenmark Pharmaceuticals (and Glenmark Generics) Recent Developments/Updates
 Table 135. Apotex Inc. (and Apotex Corporation) Company Information
 Table 136. Apotex Inc. (and Apotex Corporation) Description and Business Overview
 Table 137. Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Product
 Table 139. Apotex Inc. (and Apotex Corporation) Recent Developments/Updates
 Table 140. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Company Information
 Table 141. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Description and Business Overview
 Table 142. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Product
 Table 144. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Ranitidine (Zantac) Distributors List
 Table 148. Ranitidine (Zantac) Customers List
 Table 149. Ranitidine (Zantac) Market Trends
 Table 150. Ranitidine (Zantac) Market Drivers
 Table 151. Ranitidine (Zantac) Market Challenges
 Table 152. Ranitidine (Zantac) Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Ranitidine (Zantac)
 Figure 2. Global Ranitidine (Zantac) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Ranitidine (Zantac) Market Share by Type: 2024 & 2031
 Figure 4. Ranitidine Capsule Product Picture
 Figure 5. Ranitidine Oral Tablet Product Picture
 Figure 6. Ranitidine Injectable Solution Product Picture
 Figure 7. Ranitidine Oral Syrup Product Picture
 Figure 8. Global Ranitidine (Zantac) Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Ranitidine (Zantac) Market Share by Application: 2024 & 2031
 Figure 10. Hospital Pharmacy
 Figure 11. Retail Pharmacy
 Figure 12. Online Pharmacy
 Figure 13. Global Ranitidine (Zantac) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Ranitidine (Zantac) Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Ranitidine (Zantac) Sales (2020-2031) & (K Units)
 Figure 16. Global Ranitidine (Zantac) Average Price (US$/Unit) & (2020-2031)
 Figure 17. Ranitidine (Zantac) Report Years Considered
 Figure 18. Ranitidine (Zantac) Sales Share by Manufacturers in 2024
 Figure 19. Global Ranitidine (Zantac) Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Ranitidine (Zantac) Players: Market Share by Revenue in Ranitidine (Zantac) in 2024
 Figure 21. Ranitidine (Zantac) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Ranitidine (Zantac) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Ranitidine (Zantac) Sales Market Share by Country (2020-2031)
 Figure 24. North America Ranitidine (Zantac) Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Ranitidine (Zantac) Sales Market Share by Country (2020-2031)
 Figure 28. Europe Ranitidine (Zantac) Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Ranitidine (Zantac) Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Ranitidine (Zantac) Revenue Market Share by Region (2020-2031)
 Figure 36. China Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Ranitidine (Zantac) Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Ranitidine (Zantac) Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Ranitidine (Zantac) Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Ranitidine (Zantac) Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Ranitidine (Zantac) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Ranitidine (Zantac) by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Ranitidine (Zantac) by Type (2020-2031)
 Figure 58. Global Ranitidine (Zantac) Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Ranitidine (Zantac) by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Ranitidine (Zantac) by Application (2020-2031)
 Figure 61. Global Ranitidine (Zantac) Price (US$/Unit) by Application (2020-2031)
 Figure 62. Ranitidine (Zantac) Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Ranitidine Hydrochloride Tablets Market Research Report 2024
Global Ranitidine Hydrochloride for Injection Market Research Report 2024
Global Famotidine Drugs Market Research Report 2025
Cimetidine API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Digestive System Drugs Market Research Report 2024
Global N Aminoethylpiperazine Market Research Report 2025
Global Peptic Ulcer Treatment Drugs Market Research Report 2024
Global Irritable Bowel Syndrome Drug Market Research Report 2024
Global Pentetrazol Market Research Report 2025
Global Imidapril Market Research Report 2024
Global Uracil Market Research Report 2025
Global Xylazine Market Research Report 2024
Global Gastrointestinal Device Market Research Report 2025
Global Stomach Acid Suppressing Drug Market Research Report 2024
Famotidine Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Digestive Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pediatric Digestive Drugs Market Research Report 2025
Global Phenothiazine Market Research Report 2024
Global Gastrointestinal Motility Drugs Market Research Report 2024
Global Hydralazine Market Research Report 2025

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions